Evelyn Partners Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$502K Buy
10,414
+1,005
+11% +$46.9K 0.12% 76
2025
Q4
$456K Sell
9,409
-1,783
-16% -$88.4K 0.11% 78
2025
Q3
$528K Buy
11,192
+2,288
+26% +$110K 0.12% 75
2025
Q2
$430K Buy
8,904
+1,902
+27% +$97.2K 0.11% 75
2025
Q1
$388K Buy
7,002
+538
+8% +$29.1K 0.11% 77
2024
Q4
$312K Buy
+6,464
New +$329K 0.08% 83

Other funds holding SNY

Evelyn Partners Asset Management's SNY Position: Q1 2026 in Review

Evelyn Partners Asset Management increased its Sanofi (SNY) stake by 11% in Q1 2026, buying an estimated $46.9K and bringing the position to 10,414 shares worth $502K. The position accounts for 0.12% of the portfolio, ranked #76.

Evelyn Partners Asset Management first reported a position in SNY in Q4 2024 and has held it in 6 quarters since. The position peaked at $528K in Q3 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Evelyn Partners Asset Management held 10,414 shares of Sanofi worth $502K as of Q1 2026.
  • Evelyn Partners Asset Management bought 1,005 Sanofi shares in Q1 2026, an estimated $46.9K.
  • Sanofi made up 0.12% of Evelyn Partners Asset Management's portfolio in Q1 2026, its #76 holding.
  • Evelyn Partners Asset Management first reported a position in Sanofi in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Asset Management's Sanofi position peaked at $528K in Q3 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Evelyn Partners Asset Management's 13F filing for Q1 2026, filed 15 May 2026.